Inozyme Pharma, Inc.
INZYDelisted Jul 1, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001693011
Inozyme Pharma, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 3, 2025; 87 institutions reported holding it in 13F filings for Q2 2025, worth $202.3M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Inozyme Pharma, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Inozyme Pharma, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Hopfner Robert Lorne | Director | 0Indirect | Jul 3, 2025 | 0 |
| Bolte Axel | Director | 0 | Jul 3, 2025 | 0 |
| Treco Douglas A | CEO & Chairman | 0 | Jul 3, 2025 | 0 |
| Sullivan Lynne Marie | Director | – | Jul 3, 2025 | 0 |
| Subramanian Sanjay | SVP, CFO & Head of BD | 0 | Jul 3, 2025 | 0 |
| Winton Matthew | COO | 0 | Jul 3, 2025 | 0 |
| Harris Erik | Director | – | Oct 7, 2024 | 0 |
| Diaz Reinaldo M | Director | – | Jun 20, 2024 | 0 |
| Mathers Edward T | Director | – | Jun 20, 2024 | 0 |
| Edwards Martin | Director | – | Jun 20, 2024 | 0 |
| Bhagat Sarah M | Director | – | Jun 20, 2024 | 0 |
| Pivotal bioVenture Partners Fund I, L.P. | Director | 1,571,741Indirect | Aug 3, 2023 | 0 |
| Pivotal bioVenture Partners Fund I U.G.P. Ltd | Director | 1,571,741Indirect | Aug 3, 2023 | 0 |
| Pivotal bioVenture Partners Fund I G.P., L.P. | Director | 1,571,741Indirect | Aug 3, 2023 | 0 |
| Bjarke Henric Bjorn | SVP, COO | 105,441 | Dec 19, 2022 | 0 |
| Enright Patrick G | 10% Owner | 4,174,379Indirect | Apr 21, 2022 | 0 |
| Tammenoms Bakker Juliet | 10% Owner | 4,174,379Indirect | Apr 21, 2022 | 0 |
| Longitude Venture Partners III, L.P. | 10% Owner | 4,174,379Indirect | Apr 21, 2022 | 0 |
| Longitude Capital Partners III, LLC | 10% Owner | 4,174,379Indirect | Apr 21, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2025 (view filing) | Apr 2 | 1 day | Treco Douglas ACEO & Chairman | SSale | −8.82K | $0.89 | −$7.85K | −17.7%41.0K after | |
| Apr 3, 2024 (view filing) | Apr 2 | 1 day | Treco Douglas ACEO | SSale | −7.52K | $6.94 | −$52.2K | −26.7%20.7K after | |
| Aug 3, 2023 (view filing)8:13 PM ET | Aug 1 | 2 days | Pivotal bioVenture Partners Fund I, L.P. and 2 othersDirector | PPurchase | +833.3K | $4.80 | +$4.00M | +112.9%1.57M after | 2 lotsDuplicate filing |
| Aug 3, 2023 (view filing) | Aug 1 | 2 days | Hopfner Robert LorneDirector | PPurchase | +833.3K | $4.80 | +$4.00M | +112.9%1.57M after | 2 lots |
| May 15, 2023 (view filing) | May 11-12 | 4 days | Hopfner Robert LorneDirector | PPurchase | +447.9K | $6.36 | +$2.85M | +13.9%3.66M after | 2 lots |
| Mar 30, 2023 (view filing) | Mar 29 | 1 day | Hopfner Robert LorneDirector | PPurchase | +344.6K | $4.54 | +$1.56M | +12.0%3.21M after | |
| Mar 29, 2023 (view filing) | Mar 27-28 | 2 days | Hopfner Robert LorneDirector | PPurchase | +207.8K | $4.05 | +$841.1K | +7.8%2.87M after | 2 lots |
| Dec 19, 2022 (view filing) | Dec 15 | 4 days | Bjarke Henric BjornSVP, COO | PPurchase | +21.5K | $1.39 | +$29.9K | +25.6%105.4K after | |
| Apr 21, 2022 (view filing)6:04 PM ET | Apr 19 | 2 days | Enright Patrick G and 3 others10% Owner | PPurchase | +1.35M | $3.69 | +$5.00M | +48.1%4.17M after | |
| Apr 20, 2022 (view filing)6:22 PM ET | Apr 19 | 1 day | Pivotal bioVenture Partners Fund I, L.P. and 2 othersDirector | PPurchase | +1.07M | $3.69 | +$3.95M | +67.2%2.66M after | Duplicate filing |
| Apr 20, 2022 (view filing) | Apr 19 | 1 day | Hopfner Robert LorneDirector | PPurchase | +1.07M | $3.69 | +$3.95M | +67.2%2.66M after | |
| Apr 20, 2022 (view filing) | Apr 19 | 1 day | Bjarke Henric BjornSVP, COO | PPurchase | +27.1K | $3.69 | +$100.0K | +50.6%80.6K after | |
| Apr 20, 2022 (view filing) | Apr 19 | 1 day | Bolte AxelChief Executive Officer | PPurchase | +67.8K | $3.69 | +$250.0K | +35.5%258.6K after | |
| Apr 20, 2022 (view filing) | Apr 19 | 1 day | Subramanian SanjaySVP, CFO | PPurchase | +27.1K | $3.69 | +$100.0K | New position27.1K after |